[go: up one dir, main page]

WO2003040389A3 - Procede de detection de substances endogenes et exogenes dans l'organisme - Google Patents

Procede de detection de substances endogenes et exogenes dans l'organisme Download PDF

Info

Publication number
WO2003040389A3
WO2003040389A3 PCT/EP2002/012431 EP0212431W WO03040389A3 WO 2003040389 A3 WO2003040389 A3 WO 2003040389A3 EP 0212431 W EP0212431 W EP 0212431W WO 03040389 A3 WO03040389 A3 WO 03040389A3
Authority
WO
WIPO (PCT)
Prior art keywords
endogenic
substances
organism
identifying
exogenic
Prior art date
Application number
PCT/EP2002/012431
Other languages
German (de)
English (en)
Other versions
WO2003040389A2 (fr
Inventor
Florian Schweigert
Original Assignee
Florian Schweigert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Florian Schweigert filed Critical Florian Schweigert
Priority to AU2002350673A priority Critical patent/AU2002350673A1/en
Publication of WO2003040389A2 publication Critical patent/WO2003040389A2/fr
Publication of WO2003040389A3 publication Critical patent/WO2003040389A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N2030/009—Extraction

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne un procédé permettant la détection et/ou la différenciation simultanées de substances endogènes et exogènes, notamment de substances comprenant au moins une liaison peptidique, dans un organisme. Selon l'invention, les substances corporelles endogènes et exogènes présentes dans la matière corporelle prélevée, notamment la matière corporelle prélevée chez un organisme humain ou animal, sont concentrées sur un matériau de support, puis ces substances sont mises en évidence par leurs différentes masses et/ou différenciées.
PCT/EP2002/012431 2001-11-07 2002-11-07 Procede de detection de substances endogenes et exogenes dans l'organisme WO2003040389A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002350673A AU2002350673A1 (en) 2001-11-07 2002-11-07 Method for identifying endogenic and exogenic substances in an organism

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10155692.6 2001-11-07
DE2001155692 DE10155692A1 (de) 2001-11-07 2001-11-07 Verfahren zum Nachweis von endogenen und exogenen Stoffen im Organismus

Publications (2)

Publication Number Publication Date
WO2003040389A2 WO2003040389A2 (fr) 2003-05-15
WO2003040389A3 true WO2003040389A3 (fr) 2004-03-11

Family

ID=7705576

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/012431 WO2003040389A2 (fr) 2001-11-07 2002-11-07 Procede de detection de substances endogenes et exogenes dans l'organisme

Country Status (3)

Country Link
AU (1) AU2002350673A1 (fr)
DE (1) DE10155692A1 (fr)
WO (1) WO2003040389A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006041644B4 (de) * 2006-08-23 2011-12-01 Panatecs Gmbh Verfahren zur Detektion von Modifikationen in einem Protein oder Peptid
DE102009015740A1 (de) * 2009-03-31 2010-10-14 Siemens Aktiengesellschaft Formmasse zur Erkennung der Krankheitserreger im Mund

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998047922A2 (fr) * 1997-04-21 1998-10-29 Glycozyme, Inc. Recherche des proteines et peptides glycosiles dans des fluides biologiques
WO1999058979A1 (fr) * 1998-05-13 1999-11-18 South Eastern Sydney Area Health Service Procede servant a controler la viabilite du tissu pancreatique
WO2001092890A1 (fr) * 2000-05-26 2001-12-06 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Procede d'analyse de glucides presents en quantites picomolaires

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6777A (en) * 1849-10-09 Churn
US5895765A (en) * 1997-06-30 1999-04-20 Bayer Corporation Method for the detection of an analyte by immunochromatography
US6054047A (en) * 1998-03-27 2000-04-25 Synsorb Biotech, Inc. Apparatus for screening compound libraries
CA2240325A1 (fr) * 1998-03-27 1998-11-14 Synsorb Biotech, Inc. Methodes de criblage de banques de constituants
CA2243230A1 (fr) * 1998-07-15 2000-01-15 Aled Edwards Dispositif et methode pour la determination des limites du domaine des proteines
EP1010981A1 (fr) * 1998-12-18 2000-06-21 Diagor GmbH Conjugés pour détection de virus et leur utilisation
CA2385743A1 (fr) * 1999-09-28 2001-04-05 Universitat Zurich Facteurs ayant une activite de liaison au prion dans du serum ou du plasma et agents permettant de detecter l'encephalopathie spongiforme transmissible
AU1861001A (en) * 1999-11-29 2001-06-12 Syntesome Gesellschaft Fur Medizinische Biochemie Mbh Arrays of glycan molecules (glycoarrays) on the surface of biochips (glycochips)and uses thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998047922A2 (fr) * 1997-04-21 1998-10-29 Glycozyme, Inc. Recherche des proteines et peptides glycosiles dans des fluides biologiques
WO1999058979A1 (fr) * 1998-05-13 1999-11-18 South Eastern Sydney Area Health Service Procede servant a controler la viabilite du tissu pancreatique
WO2001092890A1 (fr) * 2000-05-26 2001-12-06 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Procede d'analyse de glucides presents en quantites picomolaires

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LASNE ET AL: "Recombinant erythropoietin in urine", NATURE, MACMILLAN JOURNALS LTD. LONDON, GB, vol. 405, 8 June 2000 (2000-06-08), pages 635, XP002211031, ISSN: 0028-0836 *
WIDE LEIF ET AL: "Detection in blood and urine of recombinant erythropoietin administered to healthy men", MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, vol. 27, no. 11, 1995, pages 1569 - 1576, XP009019184, ISSN: 0195-9131 *

Also Published As

Publication number Publication date
DE10155692A1 (de) 2003-05-22
WO2003040389A2 (fr) 2003-05-15
AU2002350673A1 (en) 2003-05-19

Similar Documents

Publication Publication Date Title
IL162950A (en) System and method for detecting and classifying biological particles
WO2004073864A3 (fr) Dispositifs de retrait de composants au cours d'une prise de sang et utilisations correspondantes
ZA983496B (en) Methods for processing activated protein C.
AU2003203090A1 (en) Method for distinguishing between protein variants
WO2001036487A3 (fr) Fragments de liaison a l'antigene specifiques aux cellules dendritiques, compositions et methodes d'utilisation, antigenes ainsi reconnus et cellules ainsi obtenues
AU2003228642A1 (en) System and method for collecting dna and fingerprints
EP1348961A4 (fr) Puces proteiques, leur procede de production, leur systeme de detection et le procede de mise en route du systeme de detection
WO2002057783A3 (fr) Methodes de criblage de ligands gpr40
IL163128A (en) Method for isolating human tissue from olfactory neuroepithelium cells, uses thereof and method using the same
WO2003040389A3 (fr) Procede de detection de substances endogenes et exogenes dans l'organisme
AU2003264343A1 (en) Method for separating platinum group element
AU2002211115A1 (en) Process for recovering proteins from whey protein containing feedstocks
AU2003240558A1 (en) Biological results evaluation method
EP0861838A3 (fr) Procédés et intermédiaires pour la préparation de composés de cryptophycine
WO2004011401A3 (fr) Procede de fabrication de puces biologiques
WO2003040729A3 (fr) Procede de detection de particules apathogenes et de leurs variantes pathogenes et/ou pathognostiques dans l'organisme
WO2005027871A3 (fr) Procede de preparation de microparticules bioresorbables sans stabilisant et sans tensioactif
HUP0002334A3 (en) Multiparticulate pharmaceutical form, particles constituting it, method and plant for making same
EP1452597A4 (fr) Procede d'activation de proteine
WO1999001475A3 (fr) Anticorps humain diriges contre un (poly)peptide ou une proteine hybride comportant une partie presentant au moins six histidines
WO2001092321A3 (fr) Proteines intervenant dans la cytoadhesion de plasmodium falciparum d'erythrocytes infectes au stade annulaire, anticorps se liant aux proteines, methodes de detection de l'infection, de stades de l'infection, et vaccins pour la protection contre l'infection
AU2002359310A1 (en) Treating diseases mediated by metalloprotease-shed proteins
WO2002004661A3 (fr) Procede de classification d'acides nucleiques et de polypeptides
WO1999009156A3 (fr) Proteine apparentee aux proteases
AU2003300497A1 (en) Method for the preparation of a collection of biological sample material, and sample collection

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: FESTSTELLUNG EINES RECHTSVERLUSTS NACH REGEL 69(1) EPUE (EPA FORM 1205A VOM 16.08.2004)

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP